No Data
Zhuhai Huajin Capital's (SZSE:000532) Returns On Capital Not Reflecting Well On The Business
Advanced Fiber Resources (Zhuhai) (SZSE:300620) May Have Issues Allocating Its Capital
Shingles Therapeutics Pipeline Market Insights Report 2024 Featuring Zhuhai Trinomab, Nobelpharma, Dynavax Technologies, Jiangsu Rec-Biotechnology, Moderna, Curevo, and Amytrx Therapeutics
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Zhuhai Guanyu (688772.SH): net income in the first half of the year was 102 million yuan, a year-on-year decrease of 27.53%.
On August 15th, Gelon Hui announced its 2024 interim report. During this period, revenue was 5.347 billion yuan, a decrease of 2.31% year-on-year. Net income attributable to shareholders of the listed company is 0.102 billion yuan, down 27.53% YoY. Deducting non-recurring gains and losses, net profit attributable to shareholders of the listed company was 25.992 million yuan, a decrease of 72.62% YoY. Basic earnings per share were 0.09 yuan. Net income attributable to shareholders of the listed company decreased by 27.53% YoY, and net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses decreased compared to the same period last year.
Zhuhai CosMX Battery (SHSE:688772) May Have Issues Allocating Its CapitalNo Data
